Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: A cross sectional study

Epilepsy Research

Volumn 107, Issue 1-2, 2013, Pages 121-126

  Sankhyan, Naveen ^a   Gulati, Sheffali ^a   Hari, Smriti ^a   Kabra, Madhulika ^a   Ramakrishnan, Lakshmy ^a   Kalra, Veena ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adverse effects; Anticonvulsants; Coronary artery disease; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CARBAMAZEPINE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PHENYTOIN;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; BRACHIAL FLOW MEDIATED DILATATION; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY; CELL FUNCTION; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; ECHOGRAPHY; ENDOTHELIUM CELL; EPILEPSY; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; MONOTHERAPY; NON INVASIVE PROCEDURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT DURATION; WAIST HIP RATIO;

ADVERSE EFFECTS; ANTICONVULSANTS; CORONARY ARTERY DISEASE; MYOCARDIAL INFARCTION;

ANTICONVULSANTS; ATHEROSCLEROSIS; CARBAMAZEPINE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; EPILEPSY; FEMALE; HUMANS; MALE; PHENYTOIN;

EID: 84886952106     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.08.011     Document Type: Article

References (22)

1. Aynaci F.M., Orhan F., Orem A., Yildirmis S., Gedik Y. Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. Journal of Child Neurology 2001, 16(5):367-369.
2. Barrett-Connor E., Khaw K.T., Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England Journal of Medicine 1986, 315(24):1519-1524.
3. Chuang Y.-C., Chuang H.-Y., Lin T.-K., Chang C.-C., Lu C.-H., Chang W.-N., Chan S.H.H. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012, 53(1):120-128.
4. De Juan Frigola J., Crespo Hernández M., Braga Hernández S. The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population. Anales españoles de pediatría 1996, 44(2):133-138.
5. Eirís J.M., Lojo S., Del Río M.C., Novo I., Bravo M., Pavón P., Castro-Gago M. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995, 45(6):1155-1157.
6. Eirís J., Novo-Rodríguez M.I., Del Río M., Meseguer P., Del Río M.C., Castro-Gago M. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Research 2000, 41(1):1-7.
7. Erdemir A., Cullu N., Yiş U., Demircioǧlu F., Kir M., Cakmakçi H., Dirik E. Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain & Development 2009, 31(10):713-716.
8. Forsgren L. Incidence and prevalence. Epilepsy in Children 2004, 21-26. Hodder Arnold, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi. S.J. Wallace, K. Farrell (Eds.).
9. Groner J.A., Joshi M., Bauer J.A. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics 2006, 118(4):1683-1691.
10. Hamed S.A., Hamed E.A., Hamdy R., Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Research 2007, 74(2-3):183-192.
11. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Rand W.M., Udelson J.E., Karas R.H. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. Journal of the American College of Cardiology 2001, 38(7):1843-1849.
12. Muuronen A., Kaste M., Nikkilä E.A., Tolppanen E.M. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. British Medical Journal (Clinical Research Ed.) 1985, 291(6507):1481-1483.
13. O'Neill B., Callaghan N., Stapleton M., Molloy W. Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin. Acta Neurologica Scandinavica 1982, 65(2):104-109.
14. Peters S.A., den Ruijter H.M., Bots M.L. The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: a systematic review. Annals of Medicine 2012, 44(4):305-312.
15. Peters S.A., den Ruijter H.M., Bots M.L., Moons K.G. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012, 98(3):177-184.
16. Sonmez F.M., Demir E., Orem A., Yildirmis S., Orhan F., Aslan A., Topbas M. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. Journal of Child Neurology 2006, 21(1):70-74.
17. Tan T.-Y., Lu C.-H., Chuang H.-Y., Lin T.-K., Liou C.-W., Chang W.-N., Chuang Y.-C. Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 2009, 50(6):1579-1586.
18. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(2 Suppl. 4th Report):555-576.
19. Tokgoz H., Aydin K., Oran B., Kiyici A. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate. Childs Nervous System 2012, 28(7):1049-1053.
20. Verrotti A., Basciani F., Domizio S., Sabatino G., Morgese G., Chiarelli F. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatric Neurology 1998, 19(5):364-367.
21. Verrotti A., Domizio S., Angelozzi B., Sabatino G., Morgese G., Chiarelli F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. Journal of Paediatrics and Child Health 1997, 33(3):242-245.
22. Voudris K.A., Attilakos A., Katsarou E., Drakatos A., Dimou S., Mastroyianni S., Garoufi A. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Research 2006, 70(2-3):211-217.